| |
NGT
(n=2,130) |
i-IFG
(n=113) |
i-IGT
(n=315) |
IFG/IGT
(n=69) |
NDD
(n=108) |
Known diabetes
(n=228) |
| Hemoglobin |
OR (95% CI) |
OR (95% CI) |
OR (95% CI) |
OR (95% CI) |
OR (95% CI) |
OR (95% CI) |
| a Model 1 |
1.00 |
1.19 (0.93-1.51) |
1.50 (1.28-1.75) |
1.92 (1.41-2.62) |
1.48 (1.15-1.90) |
0.92 (0.77-1.09) |
| b Model 2 |
1.00 |
1.03 (0.80-1.33) |
1.37 (1.16-1.62) |
1.63 (1.18-2.26) |
1.26 (0.97-1.63) |
0.90 (0.75-1.09) |
| Hematocrit |
|
|
|
|
|
|
| a Model 1 |
1.00 |
1.15 (0.91-1.46) |
1.43 (1.23-1.67) |
1.69 (1.25-2.29) |
1.47 (1.15-1.87) |
0.91 (0.77-1.07) |
| b Model 2 |
1.00 |
1.02 (0.79-1.30) |
1.33 (1.12-1.57) |
1.48 (1.08-2.04) |
1.29 (1.00-1.66) |
0.89 (0.74-1.07) |
| Platelet count |
|
|
|
|
|
|
| a Model 1 |
1.00 |
1.11 (0.92-1.33) |
0.99 (0.87-1.12) |
0.78 (0.60-1.03) |
1.00 (0.82-1.22) |
0.84 (0.72-0.99) |
| b Model 2 |
1.00 |
1.11 (0.92-1.35) |
0.99 (0.86-1.12) |
0.80 (0.60-1.06) |
1.02 (0.84-1.25) |
0.88 (0.75-1.03) |
| Mean platelet volume |
|
|
|
|
|
|
| a Model 1 |
1.00 |
1.10 (0.91-1.33) |
1.04 (0.86-1.27) |
1.24 (0.99-1.56) |
1.04 (0.86-1.27) |
1.27 (1.11-1.46) |
| b Model 2 |
1.00 |
1.08 (0.89-1.31) |
1.02 (0.90-1.16) |
1.18 (0.93-1.49) |
0.98 (0.80-1.20) |
1.19 (1.02-1.38) |
| White blood cell count |
|
|
|
|
|
|
| a Model 1 |
1.00 |
1.15 (0.93-1.44) |
1.47 (1.30-1.67) |
1.37 (1.06-1.76) |
1.68 (1.44-1.96) |
1.61 (1.40-1.84) |
| b Model 2 |
1.00 |
1.09 (0.85-1.38) |
1.46 (1.27-1.66) |
1.27 (0.97-1.68) |
1.55 (1.31-1.83) |
1.43 (1.23-1.66) |
NGT: Normal Glucose Tolerance; i-IFG: Isolated Impaired Fasting Glucose; i-IGT: Isolated Impaired Glucose Tolerance; NDD: Newly Detected Diabetes; Odds ratio (OR)
expressed per SD-increment; significant findings are highlighted in bold characters;
aModel 1: adjusted for age;
b Model 2: adjusted for age, actual hypertension, regular
smoking, physical activity, alcohol intake, total cholesterol, HDL cholesterol, creatinine, and BMI |
| Table 2: Association of hematological parameters with i-IFG, i-IGT, IFG/IGT, NDD, and known diabetes (comparisons with NGT), KORA F4 study, total sample (N=2,963). |
